Literature DB >> 21448218

GOT to rid the body of excess glutamate.

Vivian I Teichberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21448218      PMCID： PMC3130327          DOI： 10.1038/jcbfm.2011.46

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  9 in total

1.  Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials.

Authors:  Maria Philip; Michael Benatar; Marc Fisher; Sean I Savitz
Journal:  Stroke       Date:  2008-12-12       Impact factor: 7.914

2.  Brain neuroprotection by scavenging blood glutamate.

Authors:  Alexander Zlotnik; Boris Gurevich; Sergei Tkachov; Ilana Maoz; Yoram Shapira; Vivian I Teichberg
Journal:  Exp Neurol       Date:  2006-10-02       Impact factor: 5.330

3.  Circadian variations in plasma and erythrocyte glutamate concentrations in adult men consuming a diet with and without added monosodium glutamate.

Authors:  P J Tsai; P C Huang
Journal:  J Nutr       Date:  2000-04       Impact factor: 4.798

4.  High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke.

Authors:  Francisco Campos; Tomás Sobrino; Pedro Ramos-Cabrer; Mar Castellanos; Miguel Blanco; Manuel Rodríguez-Yáñez; Joaquín Serena; Rogelio Leira; José Castillo
Journal:  J Cereb Blood Flow Metab       Date:  2011-01-26       Impact factor: 6.200

5.  Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study.

Authors:  Francisco Campos; Tomás Sobrino; Pedro Ramos-Cabrer; Bárbara Argibay; Jesús Agulla; María Pérez-Mato; Raquel Rodríguez-González; David Brea; José Castillo
Journal:  J Cereb Blood Flow Metab       Date:  2011-01-26       Impact factor: 6.200

6.  Duration of glutamate release after acute ischemic stroke.

Authors:  A Dávalos; J Castillo; J Serena; M Noya
Journal:  Stroke       Date:  1997-04       Impact factor: 7.914

7.  Neurotransmitters and pathophysiology of stroke: evidence for the release of glutamate and other transmitters/mediators in animals and humans.

Authors:  A Dávalos; A Shuaib; N G Wahlgren
Journal:  J Stroke Cerebrovasc Dis       Date:  2000-11       Impact factor: 2.136

8.  Blood-mediated scavenging of cerebrospinal fluid glutamate.

Authors:  Miroslav Gottlieb; Yin Wang; Vivian I Teichberg
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

Review 9.  Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies.

Authors:  V I Teichberg; K Cohen-Kashi-Malina; I Cooper; A Zlotnik
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590
  9 in total
  9 in total

1.  The preclinical discovery of amyotrophic lateral sclerosis drugs.

Authors:  Marcie A Glicksman
Journal:  Expert Opin Drug Discov       Date:  2011-10-25       Impact factor: 6.098

Review 2.  Extracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.

Authors:  Agzam Zhumadilov; Matthew Boyko; Shaun E Gruenbaum; Evgeny Brotfain; Federico Bilotta; Alexander Zlotnik
Journal:  Expert Rev Neurother       Date:  2015-04-12       Impact factor: 4.618

3.  Blood glutamate grabbing does not reduce the hematoma in an intracerebral hemorrhage model but it is a safe excitotoxic treatment modality.

Authors:  Andrés da Silva-Candal; Alba Vieites-Prado; María Gutiérrez-Fernández; Ramón I Rey; Bárbara Argibay; David Mirelman; Tomás Sobrino; Berta Rodríguez-Frutos; José Castillo; Francisco Campos
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-04       Impact factor: 6.200

Review 4.  Glutamate, T cells and multiple sclerosis.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2017-02-24       Impact factor: 3.575

5.  Neuroprotective effect of oxaloacetate in a focal brain ischemic model in the rat.

Authors:  L Knapp; L Gellért; K Kocsis; Z Kis; T Farkas; L Vécsei; J Toldi
Journal:  Cell Mol Neurobiol       Date:  2014-05-08       Impact factor: 5.046

6.  Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.

Authors:  Matthew Boyko; David Stepensky; Benjamin F Gruenbaum; Shaun E Gruenbaum; Israel Melamed; Sharon Ohayon; Michael Glazer; Yoram Shapira; Alexander Zlotnik
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

Review 7.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

8.  MRS of brain metabolite levels demonstrates the ability of scavenging of excess brain glutamate to protect against nerve agent induced seizures.

Authors:  Angela Ruban; Inbal E Biton; Arik Markovich; David Mirelman
Journal:  Int J Mol Sci       Date:  2015-02-02       Impact factor: 5.923

Review 9.  Blood glutamate scavenging: insight into neuroprotection.

Authors:  Akiva Leibowitz; Matthew Boyko; Yoram Shapira; Alexander Zlotnik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.